FDA Approves Zepbound (tirzepatide) for Chronic Weight Management

FDA Approves Zepbound (tirzepatide) for Chronic Weight Management

The U.S. Food and Drug Administration (FDA) approved Eli Lilly and Company’s (NYSE: LLY) Zepbound™ (tirzepatide) injection, the first and…

Read More »